ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

48 hedge funds and large institutions have $145M invested in Alpine Immune Sciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 7 closing their positions.

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$3.23M
2
SCM
2
Soleus Capital Management
Connecticut
$3.32M
3
APM
3
Avidity Partners Management
Texas
$16M
4
Deutsche Bank
4
Deutsche Bank
Germany
$2.59M
5
OM
5
Opaleye Management
Massachusetts
$1.66M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$57K
2
FCM
2
Farallon Capital Management
California
$0
3
CCM
3
CAAS Capital Management
New York
$0
4
EI
4
EAM Investors
California
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$4.21M
Name Market Value Shares Shares
Change 		Shares
Change %
6CM
51
683 Capital Management
New York
– – -23,493 Closed
JPMorgan Chase & Co
52
JPMorgan Chase & Co
New York
– – -5,830 Closed
Federated Hermes
53
Federated Hermes
Pennsylvania
– – -236 Closed
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
– – -8 Closed
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
56
Simplex Trading
Illinois
– – – –
SFS
57
Sowell Financial Services
Arkansas
$0 10 +10 New
1 2
3